An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal Cancer

Condition:   Rectal Cancer Interventions:   Drug: Capecitabine (Xeloda) Pharmacogenetic Test Reagents;   Drug: irinotecan;   Radiation: IMRT;   Drug: Oxaliplatin;   Drug: 5Fluorouracil;   Drug: Tislelizumab Sponsor:   Fudan University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials